N. van As

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy

Gerard G. Hanna, Louise Murray, R. Patel et al. · Clinical Oncology · 2017 · 267 citations · Full text

Adaptive Radiotherapy, Radiation Medicine, Medical Imaging +8

UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy

Patricia Díez, Gerard G. Hanna, K. Aitken et al. · Clinical Oncology · 2022 · 117 citations

Radiation Medicine, Uk 2022, Medical Imaging +10

Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences

Piet Ost, B.A. Jereczek-Fossa, N. van As et al. · Clinical Oncology · 2016 · 115 citations

Adaptive Radiotherapy, Urology, Surgical Oncology +8

122: CORE: A randomised trial of COnventional care versus Radioablation (stereotactic body radiotherapy) for Extracranial oligometastases

V. Khoo, Merina Ahmed, Fiona McDonald et al. · Lung Cancer · 2017 · 14 citations

Neuro-oncology, Interventional Neuroradiology, Radiation Therapy +9

Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease

Luke Nicholls, Ewan Chapman, Vincent Khoo et al. · Clinical Oncology · 2021 · 12 citations

Urology, Genitourinary Cancer, Metastasis-directed Therapy +8